Related Experiment Videos
Sinonasal malignant lymphomas: a distinct clinicopathological category
The Annals of Otology, Rhinology, and Laryngology
|April 24, 1999
Summary
Sinonasal lymphomas, cancers of the head and neck, are more common in Asia. Advances in immunohistochemistry have differentiated these lymphomas into B-cell, T-cell, and natural killer (NK) cell types.
Area of Science:
- Oncology
- Hematology
- Pathology
Background:
- Sinonasal lymphomas are a specific category of extranodal lymphomas affecting the head and neck.
- While uncommon in Western nations, they are the second most prevalent extranodal lymphoma in Asian populations, following gastrointestinal lymphomas.
- Immunohistochemistry has enabled classification into B-cell, T-cell, and natural killer (NK) cell phenotypes.
Purpose of the Study:
- To differentiate sinonasal lymphomas based on immunophenotype.
- To describe the epidemiological and clinical characteristics of different sinonasal lymphoma subtypes.
- To highlight the diagnostic challenges and treatment approaches for these tumors.
Main Methods:
- Utilized immunohistochemistry to classify sinonasal lymphomas.
- Reviewed epidemiological data regarding prevalence in different global populations.
- Analyzed clinical presentation, growth patterns, and patient demographics.
Main Results:
- B-cell phenotype lymphomas are predominantly found in the paranasal sinuses, more common in Western countries.
- T/NK-cell phenotype lymphomas are prevalent in Asian and South American populations, typically located in the nasal cavity.
- These aggressive tumors exhibit angioinvasion, necrosis, and bony erosion, historically misdiagnosed as lethal midline granuloma.
Conclusions:
- Sinonasal lymphomas exhibit distinct epidemiological and clinical features based on immunophenotype.
- The T/NK-cell phenotype is more common in Asia and South America, presenting aggressively in the nasal cavity.
- Despite aggressive features, prognosis can be favorable compared to nodal lymphomas, with combined radiation and chemotherapy treatment.